Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria

Table 3 Total costs of an average severe/non-severe hypoglycaemia event

	Cost per hypoglycaemic event in patients with T1DM, T2DM_BOT, T2DM_B/B
	Non-severe daytime	Non-severe nocturnal	Severe
TOTAL (BGN)/event (2014)	0.66	33.60	514.36
TOTAL (BGN)/event (inflated to 2018)	0.65	33.19	508.10

Abbreviations: B/B Basal-bolus, BGN Bulgarian LEV, BOT Basal oral therapy, T1DM Type 1 diabetes mellitus, T2DM Type 2 diabetes mellitus

ISSN: 1472-6823